Objectives-Previous investigations have suggested that recurrent rebound thrombocytosis after alcohol misuse may be a factor in the pathogenesis of thromboembolic disease. Alcohol consumption, platelet count, and platelet function were examined among patients of working age with brain infarction. Methods-Platelet count and risk factors for stroke were studied in 426 stroke patients and 157 control patients in hospital. The measures were platelet count obtained within four days after the stroke onset, in vitro adenosine diphosphate induced platelet aggregation, associated thromboxane B2 formation, and urinary excretion of 1 -dehydrothromboxane B2. Results-After adjustment for sex, age, cardiac disease, diabetes, and alcohol intake, hypertension (OR 3 4, 95% confidence interval (95% CI) 2.0-6.0) and current smoking (OR 2-1, 95% CI 1P4-3.3)
were associated with an increased risk for brain infarction. Platelet count shortly after the onset of disease was higher in the stroke patients than in the controls (OR 1.051101011 platelets; 95% CI 1-02-1-09). The patients with brain infarction who were heavy alcohol drinkers (n = 144) showed both thrombocytosis (OR 2-30, 95% CI 0.82-6.44) and thrombocytopenia (OR [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , 95% CI 1*19 to 8.59) more often at the onset of the stroke than the other patients with brain infarction. The thromboxane variables showed inconsistent associations with the onset of stroke. There was no consistent platelet abnormality among alcohol misusers at the onset of ischaemic brain infarction. Conclusions-Alcohol induced thrombocytopenia and rebound thrombocytosis were both often seen at the onset of brain infarction in patients who were heavy alcohol drinkers. Therefore, other mechanisms which could contribute to the high frequency of recurrences of ischaemic stroke among heavy drinkers should be investigated. The role of platelets in the pathogenesis of vascular diseases is important. Platelet count and function after the onset of acute stroke and among patients with previous stroke have been intensively studied, but few studies deal with reactive thrombocytoses, although such conditions can be considered to contribute to stroke onset as predisposing factors. Probably the most common of the reactive thrombocytoses is rebound thrombocytosis after alcohol misuse, a condition which, in about one third of the patients, follows acute withdrawal from prolonged heavy alcohol drinking.' Haselager and Vreeken described, in 1977, two alcoholic men having reactive thrombocytosis concomitant with an unexplained recurrent venous thrombosis and pulmonary embolism and they hypothesised that the alcohol induced rebound thrombocytosis could precipitate thromboembolic disease.2 Heavy drinking of alcohol has been found to be a risk factor for ischaemic stroke34 and also the rate of recurrences of ischaemic stroke seems to increase in patients who are heavy drinkers.5
As we have also seen alcoholic patients with recurrent thromboembolic diseases and thrombocytosis, we became interested in the role of platelets and alcohol consumption at the onset of brain infarction. Problem drinking was assessed with the short CAGE questionnaire, which has been described in detail elsewhere. 6 The CAGE interview includes four questions on abnormal drinking behaviour, and patients with two or more positive answers are considered CAGE positive; CAGE positivity is a sensitive indicator of previous and current extensive drinking. The patients who were CAGE positive or whose regular weekly alcohol intake exceeded 300 g ethanol were included in the category of heavy drinkers.
LABORATORY PROCEDURES
Blood samples for measurements of platelet count were taken from all the patients within three days of admission. Further samples were taken from a random subsample of 13 patients one week and more than two weeks after the onset of stroke. None of these 13 patients had taken any drugs known to influence platelet function during the week before admission.
The studies of platelet function included adenosine diphosphate induced irreversible platelet aggregation and associated thromboxane B2 (TxB2) formation. Blood was collected with minimal stasis via a plastic cannula into tubes containing 3-8% sodium citrate. Platelet rich plasma (PRP) and platelet poor plasma (PPP) were centrifuged and used to adjust the platelet count of PRP to 250 x 109/1. Platelet aggregations were measured with a dual channel aggregometer (Chrono-Log, Coulter Electronics Ltd, UK) starting 45 minutes after the blood sampling. Aggregation in PRP was induced by adenosine diphosphate (final concentration 8 or 16 gjM) to yield an irreversible aggregation. The reaction was stopped by 1 mmol/l HC1 after five minutes and aggregated PRP samples were frozen for further analyses. Thromboxane B2 was measured from aggregated PRP by a radioimmunoassay (Amersham International, UK). In addition, 24 hour urine samples were collected from a random subsample of 11 patients for urinary 1 1-dehydrothromboxane B2 analyses. This is a stable metabolite of TxA2 in urine, which could reflect platelet aggregation in vivo.7 8 1 1-DehydroTxB2 was analysed by enzyme linked immunosorbent assay (ELISA) (Cayman Co, USA) from samples taken on the same days as the blood samples for platelet function measurements.
The erytlrocyte mean volume (MCV, normal range, 80 to 96 fl) was used as a laboratory marker of alcohol consumption, because it was routinely available for most patients (92%) and controls (99%). Besides heavy drinking, cigarette smoking has also been shown to raise MCV9 and diabetic patients may have slightly raised r glutamyl transferase (GGT). The value (normal range, 0-45 U/1) was available for 393 patients (92%) and 94 (60%) control patients.
STATISTICAL METHODS
The data were analysed with the BioMedical Data Package statistical programs (BMDP Statistical Software Inc, version 1993, University of California at Los Angeles). The categorical variables were compared with the Pearson X2 test, the test for linear trend, or the Mantel-Haenszel statistics. The continuous variables, which were expressed as mean (SD) or median with the 25th and 75th percentiles (if the distribution was skewed), were compared with the Student's t test, Mann-Whitney U test, or Spearman's rank correlation coefficients (rs) when appropriate. The odds ratios (OR) with 95% confidence intervals (95% CIs) before and after adjustment for potential confounding variables were calculated by logistic regression. The 95% CIs for the logistic coefficients were estimated using the standard errors. In all statistical testing performed the significance was accepted at P < 0.05.
Results Table 1 presents the baseline characteristics, previous diseases, and health habits of the patients.The occurrence of most cardiovascular risk factors was more frequent in the patients than the control patients. Only hyperlipaemia and atrial fibrillation showed a nonsignificant difference. The GGT values were 378~~~~~~~~~~~~~~~~~~~~~~~~~~N umminen, Hilibom, J7uvela 
Urinary 1 1-dehydroTxB2 values were available for 11 patients. The range varied from 261 to 3552 pmol/mmol/g urinary creatinine.
The values did not show any significant correlations with the corresponding platelet counts, aggregation percentages, or values for formation of TxB2 in vitro.
Discussion
Platelet count was shown to associate positively with risk of ischaemic stroke after adjustment for potential risk factors, including habitual heavy drinking and recent alcohol consumption. Higher than normal platelet counts on admission were more frequent among the patients with brain infarction than among the control patients. The multivariate analysis indicated that a high platelet count was independently associated with the onset of brain infarction.
There is no uniform agreement whether platelet count is increased or decreased at onset of stroke. Platelet count may be decreased because platelets are consumed during thrombogenesis.'011 However, not all investigations agree with this notion, but rather suggest that thrombocytopenia and associated large platelets are likely to precede the vascular event.'2 Higher than normal platelet counts have also been reported to occur in patients with brain infarction.'3 The above mentioned findings were made among elderly stroke patients and our study cannot consider this question, because we did not know the platelet count immediately before the onset of stroke in our patients. At best, we can say that there is a relation between the occurrence of brain infarction and raised platelet counts immediately after the onset of stroke. However, it is difficult to believe that brain infarction had, within three days, caused the pronounced thrombocytosis which occurred in eight patients.
The factors known to provoke reactive thrombocytosis include exercise, haemorrhage, acute and chronic inflammatory disorders, malignant diseases, haemolysis, splenectomy, major surgery, certain drug treatments, and withdrawal from prolonged alcohol drinking. Infections and heavy drinking are of particular interest, as they often precede the onset of ischaemic stroke and have been shown to be independent risk factors for brain infarction.34 '4 '5 Our main purpose was to show whether rebound thrombocytosis coincides with the time of onset of stroke among heavy drinkers of alcohol. Bias could have been possible through missing the heavy drinkers who had stopped drinking alcohol earlier than one week before the onset of the index disease. This could have led to an increased frequency of high platelet counts among the patients who were not classified as heavy drinkers. However, by using the positive answers to the CAGE questions we were able to include such patients into the group of heavy drinkers.
Thus bias due to hidden alcohol related rebound thrombocytosis is improbable. It is also unlikely that the acute diseases of the control patients could have caused haemodilution or platelet consumption and thereby decreased the platelet count. Both low and high platelet counts were found in heavily drinking patients on admission for brain infarction. Altogether, eight patients with brain infarction had definite thrombocytosis (> 450 x 109/1). Three of them had thrombocytosis because of withdrawal from recent prolonged heavy drinking of alcohol. Accordingly, alcohol related rebound thrombocytosis was not a very common finding among the patients with brain infarction who were recent heavy drinkers. We also found 15 recent heavy drinkers who had thrombocytopenia (< 151 x 109/1).
In fact, we cannot exclude the possibility that the alcohol induced rebound thrombocytosis contributed to the onset of ischaemic stroke in three of our patients. However, as recent heavy drinkers rather often had normal platelet counts and even obvious thrombocytopenia at the onset of stroke and showed an increase in platelet count and function within a week after admission-that is, several days after the onset of ischaemic stroke, the increased risk for ischaemic stroke and recurrence of stroke among heavy drinkers should be considered to result from other factors, such as cardiac insufficiency due to alcoholic cardiomyopathy and arrhythmias.
Enhanced platelet aggregability often associates with the onset of ischaemic stroke,'6 21 but it may also exist after onset of haemorrhagic stroke.22 Platelet hyperfunction may precede the onset of stroke23 or develop after onset. 24 In the presence of essential and reactive thrombocytoses platelet hyperaggregability may precipitate the onset of stroke. 23 25-27 It has been reported that three patients developed brain infarction in association with reactive thrombocytosis in the late recovery period (10-25 days) after cardiopulmonary bypass surgery28 and that an alcoholic patient developed a transient ischaemic attack while having transient thrombocytosis and enhanced platelet aggregability due to cessation of prolonged heavy drinking. 29 The few measurements of platelet function in our study were not enough to prove whether enhanced platelet function played a relevant part in the onset of stroke in our patients.
In patients having thrombocytopenia due to ethanol toxicity, the platelets are larger than normal.30 On the other hand, large platelets are more reactive than small platelets.3' Therefore, it is also possible that increased platelet reactivity already occurs in the presence of a low platelet count shortly after the cessation of drinking among recent heavy drinkers of alcohol, although platelet reactivity is usually decreased during prolonged heavy alcohol consumption. 32 In conclusion, the contribution of reactive thrombocytoses to the onset of ischaemic brain infarction remains unclear. Rebound thrombocytosis due to cessation of prolonged heavy alcohol drinking was found to be an infrequent finding at the onset of acute ischaemic brain infarction. Recent heavy drinkers often showed lower than normal platelet counts. Therefore, other mechanisms which could contribute to the high frequency of ischaemic stroke recurrences among heavy drinkers should be investigated.
